Ketamine's Stroke Risk: What You Need To Know

Ketamine is a versatile drug with a wide range of applications in medicine. It is primarily used as a dissociative anaesthetic, but it has also been used to treat several neurological conditions, including migraine, status epilepticus, stroke, and traumatic brain injury. While it is generally considered safe, there are some concerns about its potential to cause strokes. Some studies suggest that ketamine may have neuroprotective effects and could be used to treat ischemic stroke, the most common type of acute cerebrovascular disease. However, there is limited data on the potential risks associated with ketamine use, particularly in high doses or when used recreationally. Overall, while ketamine has a wide range of medical applications, more research is needed to fully understand its potential benefits and risks, especially in the context of stroke.

Ketamine's effect on the brain

Ketamine is a synthetic compound that has been used as an anesthetic in human and veterinary medicine for decades. It is also used recreationally due to its "dissociative effects", which include hallucinations and feelings of disconnection from one's feelings, thoughts, surroundings, and identity. In 2019, the FDA approved ketamine for the treatment of depression, but its usefulness is limited by its potential for abuse and psychiatric side effects.

Ketamine has a complex mechanism of action, involving multiple neurotransmitters and receptor systems in the brain. It primarily acts as a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, inhibiting glutaminergic transmission and leading to neuroprotective effects. Ketamine also binds to opioid, monoaminergic, nicotinic, and muscarinic receptors, with variable affinity. These interactions result in a range of effects on the brain, including amnesia, analgesia, and changes in cerebral blood flow and metabolism.

Recent studies have focused on understanding the effects of ketamine on specific brain regions and neurotransmitter systems. For example, researchers at Massachusetts General Hospital traced ketamine's effects to three brain regions: the prefrontal cortex, the hippocampus, and the posteromedial cortex. The first two are believed to be involved in the drug's antidepressant effects, while the third is a likely site for the dissociative effects.

Another study in mice found that repeated ketamine exposure over extended periods leads to widespread structural changes in the brain's dopamine system. This may be linked to cognitive behavioral changes and could help explain the dissociative effects observed in individuals exposed to ketamine.

In terms of its effects on cerebral blood flow and intracranial pressure (ICP), early studies reported a transient increase in ICP following ketamine use. However, more recent studies have disproven this idea, finding no persistent ICP elevation and even suggesting a potential neuroprotective role for ketamine in conditions such as stroke and traumatic brain injury (TBI).

Overall, ketamine has a diverse range of effects on the brain, and its complex pharmacology continues to be an active area of research. While it has shown promise in treating various neurological conditions, its potential for abuse and side effects highlight the need for further study to fully understand its mechanisms of action and develop targeted therapies.

Ketamine's role in treating stroke

Ketamine is a well-known anaesthetic that has been gaining popularity as a treatment for several neurological conditions, including stroke. Its potential as a neuroprotective agent has been explored in recent studies, which suggest that it can help reduce brain damage and promote recovery after a stroke.

Ketamine primarily acts as a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. This means it blocks the action of glutamate, the most abundant excitatory receptor in the central nervous system (CNS). By inhibiting glutaminergic transmission, ketamine helps protect the brain from further injury and promotes neuronal survival. This mechanism has been found to be neuroprotective in various neurological conditions, including stroke.

In addition to its NMDA receptor antagonist properties, ketamine interacts with multiple other receptors in the brain, such as opioid, monoaminergic, nicotinic, and muscarinic receptors. It also has anti-inflammatory effects, which are important in reducing the damaging inflammation that occurs after a stroke.

One of the key benefits of ketamine is its ability to maintain cerebral perfusion pressure (CPP) and increase cerebral blood flow, which helps prevent a further decrease in oxygen and glucose delivery to the brain. This is especially important in the context of stroke, where reduced blood flow to the brain can lead to neuronal injury and death.

Studies have also shown that ketamine can reduce apoptosis, or programmed cell death, by upregulating proteins that promote cell survival. Additionally, it can mitigate excitotoxicity, an extreme state of deregulation in the brain caused by a build-up of calcium, by reducing the release of glutamate and increasing blood flow to the damaged areas.

Furthermore, ketamine has been found to have beneficial effects on microthrombosis, the build-up of platelets in the tiny vessels of the brain, which can block oxygen and glucose supply to neurons. By disrupting this process, ketamine helps improve blood flow and reduce the risk of further brain damage.

While ketamine shows promise as a neuroprotective agent, more research is needed to fully understand its complex interactions with the brain and its long-term effects on stroke recovery. However, its ability to reduce primary brain damage and promote neuronal survival makes it a potential breakthrough treatment option for stroke patients.

Ketamine's side effects

Ketamine is a dissociative drug that can distort sensory perception and make users feel detached from themselves and their surroundings. It is used as an anesthetic during medical procedures and is administered by injection into a vein or muscle.

Short-term side effects

The effects of ketamine are typically felt within minutes of use and can last for several hours, and sometimes even days. The intensity of these effects depends on the amount of the drug consumed. Short-term side effects include:

• Disorientation, confusion, or loss of motor coordination
• Dizziness, nausea, or vomiting
• Increased blood pressure, heart rate, breathing, or body temperature
• Changes in sensory perceptions, including visual or auditory hallucinations
• Feeling detached from yourself, your surroundings, or your environment

Long-term side effects and dangers

The long-term effects of ketamine use have not been exhaustively studied. However, long-term risks include the development of a substance use disorder, as ketamine use is thought to be reinforcing. Additionally, ketamine use can lead to tolerance and physical dependence, with withdrawal symptoms such as depression, excessive sleepiness, and drug cravings.

Long-term ketamine misuse has also been associated with certain structural and functional changes in the brain, which could lead to memory impairments and declines in executive functioning. It can also cause serious bladder problems, abdominal pain, and evidence of liver damage is also emerging. Regular use can cause depression and, occasionally, psychotic symptoms such as hallucinations, and can make existing mental health problems worse.

Ketamine's toxicity

Ketamine toxicity can be caused by medical use or recreational misuse of the drug. It can be administered intravenously, intramuscularly, orally, or through insufflation (snorting) and smoking. The symptoms of ketamine toxicity are dose-dependent and vary depending on whether the context of administration was iatrogenic or illicit.

Symptoms

Ketamine toxicity can cause a variety of neurological, cardiovascular, psychiatric, urogenital, and abdominal symptoms. Symptoms of overdose or toxicity include:

• Respiratory depression
• Apnea
• Hypertension
• Bradycardia
• Myocardial infarction
• Seizures
• Stupor
• Coma
• Excessive salivation
• Nystagmus
• Mydriasis
• Abdominal pain
• Nausea
• Vomiting
• Altered mental status
• Paranoia
• Dysphoria
• Anxiety
• Confusion
• Slurred speech
• Dizziness
• Ataxia
• Dysarthria
• Trismus
• Muscular rigidity
• Psychomotor, psychomimetic, or acute dystonic reactions
• Lower urinary tract symptoms

Treatment

Typically, only supportive care is necessary for patients with ketamine toxicity. The effects of ketamine intoxication typically last between 15 minutes to several hours, depending on the dose, route of administration, metabolic capacity, and intrinsic sensitivity to the drug. If the patient vomits, they should be positioned to lean forward or lie on their left side to avoid aspiration. Intubation can be used to provide respiratory support. Benzodiazepines such as lorazepam and diazepam can be used to alleviate agitation, psychomimetic effects, hypertension, hyperthermia, and seizures. Butyrophenones, including haloperidol, have been used to treat psychotic episodes and agitation.

Outlook and Prevention

An individual who has experienced and recovered from acute ketamine toxicity may experience psychological disturbances, including hallucinations and unusual dreams, for days or weeks after their last use. These effects are not permanent and fade with time. However, frequent ketamine use has been linked to long-term depression, sleep issues, and deficits in memory and concentration. Psychological dependence has also been found in long-term use of ketamine, despite the absence of physical withdrawal symptoms.

Ketamine's use in palliative care

Ketamine is a dissociative anesthetic that has been used in medical practice for multiple decades. It is well-known for its ability to induce a trance-like state of consciousness, providing pain relief and sedation. In palliative care, ketamine is administered in lower doses compared to surgical settings, aiming to alleviate distressing symptoms without causing complete sedation.

Pain Management

One of the primary reasons for ketamine's use in palliative care is its effectiveness in managing pain. It is particularly useful for patients who have developed opioid tolerance or are experiencing neuropathic pain. Ketamine's mechanism of action differs from opioids, making it a valuable adjunct to conventional pain management strategies. It can be administered as an intravenous infusion or tailored to the patient's needs through other forms such as oral, nasal, intramuscular, and topical applications.

Depression and Anxiety Management

Ketamine has shown promise in rapidly alleviating symptoms of severe emotional distress, including depression and anxiety, which are common in palliative care settings. It is believed to promote the growth of new neural connections and enhance mood regulation, making it a valuable tool for addressing the emotional suffering that can accompany end-of-life care.

Reduced Opioid Use

Ketamine can help mitigate the side effects and complications associated with prolonged opioid use by supplementing or reducing the need for opioids. This approach minimizes the risk of opioid-related complications while still providing adequate pain relief.

Challenges and Considerations

While ketamine has shown great promise in palliative care, it is not without challenges. Healthcare professionals must carefully monitor and adjust dosages to decrease the risk of hallucinations and other side effects. Patient selection and evaluation are crucial to ensure that only appropriate candidates receive this treatment. Additionally, ketamine may not be suitable for all patients due to their medical history, allergies, or potential interactions with other medications.

Ketamine is emerging as a valuable tool in palliative care for pain management, mood regulation, and symptom control. Its unique mechanism of action and potential to reduce opioid use make it a promising addition to comprehensive palliative care. However, its use should be carefully considered and closely monitored by a healthcare team, with discussions involving patients and their families to make informed decisions regarding ketamine therapy.

Frequently asked questions